Inogen, Inc.

NasdaqGS INGN

Inogen, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2024: -27.38%

Inogen, Inc. Return on Equity (ROE) is -27.38% for the Trailing 12 Months (TTM) ending September 30, 2024, a 44.00% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Inogen, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2023 was -48.89%, a -250.73% change year over year.
Inogen, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2022 was -13.94%, a -547.77% change year over year.
Inogen, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 3.11%, a 621.41% change year over year.
Inogen, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2020 was -0.60%, a -106.04% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

NasdaqGS: INGN

Inogen, Inc.

CEO	Mr. Kevin R. M. Smith
IPO Date	Feb. 14, 2014
Location	United States
Headquarters	301 Coromar Drive
Employees	834
Sector	Utilities
Industries Pollution Treatment 3D Printing Biotechnology Drugstores & Retail Pharmacies Eyewear Hardware & Electronics Medical Instruments Telehealth

Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Key trends

Past 5 years